Whipplewood Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Whipplewood Advisors's AMGN Position: Q2 2026 in Review
Whipplewood Advisors reduced its Amgen (AMGN) stake by 79% in Q2 2026, selling an estimated $62K and leaving 49 shares worth $17.7K. The position accounts for 0.01% of the portfolio, ranked #204.
Whipplewood Advisors first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $117K in Q1 2025. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Whipplewood Advisors held 49 shares of Amgen worth $17.7K as of Q2 2026.
- Whipplewood Advisors sold 181 Amgen shares in Q2 2026, an estimated $62K.
- Amgen made up 0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #204 holding.
- Whipplewood Advisors first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
- Whipplewood Advisors's Amgen position peaked at $117K in Q1 2025.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.